We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$109B
AUM Growth
+$5.89B
(+5.7%)
Cap. Flow
-$3.72B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
32.97%
Holding
343
New
8
Increased
53
Reduced
229
Closed
9
Avg Time Held
5.7
years
Top 10 Avg Time Held
5
years
Top 20 Avg Time Held
5.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Splunk Inc
SPLK
|
+$164M |
| 2 |
Fidelity National Information Services
FIS
|
+$140M |
| 3 |
Intel
INTC
|
+$124M |
| 4 |
GSK
GSK
|
+$111M |
| 5 |
Mobileye
MBLY
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$753M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$370M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Charles Schwab
SCHW
|
+$197M |
| 5 |
Morgan Stanley
MS
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.81% |
| 2 | Technology | 27.17% |
| 3 | Industrials | 11.89% |
| 4 | Financials | 8.82% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Carnival Corporation Ltd
CCL
$35.6B
| $75.5M | 0.07% |
9,372,724
-106,900
| -1% | -$921K |
2013 Q2
38 quarters
|
|
152
Palo Alto Networks
PANW
$303B
| $73.4M | 0.07% |
1,051,914
-27,010
| -3% | -$2.17M |
2019 Q1
15 quarters
|
|
|
153
Mobileye
MBLY
$6.32B
| $72.3M | 0.07% |
+2,061,470
| New | +$62.6M |
2022 Q4
0 quarters
|
|
154
FormFactor
FORM
$8.85B
| $70.8M | 0.06% |
3,185,044
+153,430
| +5% | +$3.58M |
2013 Q2
38 quarters
|
|
155
Rockwell Automation
ROK
$46.9B
| $70.5M | 0.06% |
273,700
-2,295
| -0.8% | -$576K |
2013 Q2
38 quarters
|
|
156
Hilton Worldwide
HLT
$77.2B
| $69.9M | 0.06% |
553,565
| – | – |
2015 Q2
30 quarters
|
|
157
Ametek
AME
$57B
| $69.9M | 0.06% |
500,400
-1,000
| -0.2% | -$133K |
2020 Q1
11 quarters
|
|
158
McDonald's
MCD
$172B
| $69.8M | 0.06% |
264,800
| – | – |
2016 Q1
27 quarters
|
|
159
US Bancorp
USB
$89.4B
| $64.2M | 0.06% |
1,471,400
-2,096,300
| -59% | -$89.7M |
2013 Q4
36 quarters
|
|
160
Live Nation Entertainment
LYV
$40.2B
| $63.6M | 0.06% |
911,640
-66,825
| -7% | -$4.95M |
2020 Q3
9 quarters
|
|
161
Evercore
EVR
$9.87B
| $63.1M | 0.06% |
578,880
+41,680
| +8% | +$4.35M |
2021 Q4
4 quarters
|
|
162
Charles River Laboratories
CRL
$14.6B
| $62M | 0.06% |
284,740
-10,080
| -3% | -$2.2M |
2013 Q2
38 quarters
|
|
163
Xometry
XMTR
$5.71B
| $61.5M | 0.06% |
1,907,508
+360,748
| +23% | +$16.8M |
2021 Q2
6 quarters
|
|
164
Alcon
ALC
$32.2B
| $60.9M | 0.06% |
888,434
-9,910
| -1% | -$632K |
2019 Q2
14 quarters
|
|
165
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $59.9M | 0.05% |
291,450
-35,170
| -11% | -$8.89M |
2020 Q3
9 quarters
|
|
|
VMW
166
DELISTED
VMware, Inc
VMW
| $59.6M | 0.05% |
485,627
-9,219
| -2% | -$1.06M |
2013 Q2
38 quarters
|
|
167
Sanofi
SNY
$96.5B
| $58.9M | 0.05% |
1,215,740
-23,760
| -2% | -$1.04M |
2013 Q2
38 quarters
|
|
168
DELISTED
Southwestern Energy Company
SWN
| $58.5M | 0.05% |
10,005,850
-43,900
| -0.4% | -$289K |
2013 Q2
38 quarters
|
|
169
Altria Group
MO
$123B
| $55.7M | 0.05% |
1,219,524
-37,000
| -3% | -$1.68M |
2017 Q2
22 quarters
|
|
170
Las Vegas Sands
LVS
$24.8B
| $55.7M | 0.05% |
1,159,400
| – | – |
2013 Q2
38 quarters
|
|
171
Newell Brands
NWL
$2.46B
| $54.7M | 0.05% |
4,184,900
-459,600
| -10% | -$6.28M |
2014 Q1
35 quarters
|
|
172
L3Harris
LHX
$44.8B
| $52.3M | 0.05% |
251,300
| – | – |
2020 Q1
11 quarters
|
|
173
Honeywell
HON
$66.7B
| $48.9M | 0.04% |
242,226
-1,804
| -0.7% | -$345K |
2013 Q2
38 quarters
|
|
174
BJs Wholesale Club
BJ
$13B
| $47.8M | 0.04% |
722,000
-39,310
| -5% | -$2.85M |
2019 Q2
14 quarters
|
|
175
Lyft
LYFT
$6.5B
| $47.6M | 0.04% |
4,317,631
-246,750
| -5% | -$2.98M |
2019 Q1
15 quarters
|
|
Similar funds
Primecap Management's Q4 2022 Portfolio in Review
As of Q4 2022, Primecap Management held 343 positions worth $109B, up 5.7% from $103B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $3.72B in Q4 2022, closing 9 positions and reducing 229 holdings. Its most notable exit was Abiomed Inc, an estimated $370M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Mobileye worth $72.3M.
- Primecap Management's largest Q4 2022 buy was Mobileye: 2,061,470 shares worth $72.3M.
- Primecap Management added most to Splunk Inc in Q4 2022, an estimated $164M increase.
- Primecap Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $753M.
- Primecap Management fully exited Abiomed Inc in Q4 2022, selling an estimated $370M.
- Primecap Management's ten largest holdings make up 33% of its $109B portfolio in Q4 2022.
- Primecap Management opened 8 new positions and closed 9 in Q4 2022.
- Primecap Management's portfolio value rose 5.7% quarter-over-quarter to $109B.
Based on Primecap Management's 13F filing for Q4 2022, filed 13 Feb 2023.